Market Overview:
The global wound biologics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the wound biologics market can be attributed to factors such as rising incidence of chronic wounds, increasing demand for advanced wound care products, and growing awareness about advanced wound care products. Based on type, the global wound biologics market is segmented into biological skin substitutes, enzyme preparations, and growth factors. Biological skin substitutes are further sub-segmented into allografts, xenografts, and synthetic skin grafts. Enzyme preparations are further sub-segmented into proteases and carbohydrases. Growth factors are further sub-segmented into platelet rich plasma (PRP) therapy and bone marrow aspirate concentrate (BMAC) therapy. Based on application, the global wound biologics market is segmented into hospital use, drugstore use, and other uses such as homecare settings or clinics/surgeries outside hospitals setting etc.). Geographically speaking North America dominates the overall Global Wound Biologic Market followed by Europe due To high prevalence rate Of chronic wounds In these regions And also presence Of major players In this region .
Product Definition:
A wound biologic is a medical device that is used to help promote the healing of wounds. These products can come in various forms, such as creams, ointments, gels, and sprays. They are typically applied to the wound bed directly or via a secondary dressing.
Biological Skin Substitutes:
Biological skin substitutes are used for wound healing and treatment of chronic non-healing wounds. Biological skin substitutes provide a scaffold that facilitates new tissue formation along with the release of growth factors by the body's cells. The biological skin substitute market is expected to witness significant growth over the forecast period owing to increasing demand in wound care management, rising prevalence of diabetes, and other chronic conditions.
Enzyme Preparation:
Enzyme preparation is a process in which the enzymes are extracted from their natural source (bacteria, plants or animals) and purified. The final product consists of various types of enzymes that have different functions. Some of these functions include breaking down proteins, fats or cellulose; while others help digest food, clotting blood or remove toxins from the body.
Application Insights:
The others segment held the largest share of revenue in 2017. This segment includes wound care products for diabetic foot ulcers, pressure ulcers and venous leg ulcers. The increasing prevalence of chronic diseases, especially diabetes, across the globe is expected to boost product demand in this segment over the forecast period.
The hospital segment is anticipated to witness lucrative growth over the forecast period owing to rising cases of trauma and burns injuries across hospitals globally. In addition, a rise in military personnel undergoing surgeries due to various wounds is expected drive industry growth over the next few years.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as increasing road accidents, rising prevalence of chronic diseases, and presence of key players in this region. In addition, quick adoption of advanced products for wound care is expected to drive the regional market over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to increasing awareness about availability of advanced therapies for various types of wounds and rising healthcare expenditure by governments & private sectors. Presence of untapped opportunities along with high population growth rates in this region will serve it better during future expansion phases.
Major companies include Johnson & Johnson Services Inc.; Baxter International; Becton Dickerson And Company; Medtronic plc.; Orthofix Holdings Inc.; Stryker Corporation; Zimmer Biomet Holdings Inc.; Coloplast A/S; Integra LifeSciences Corp.
Growth Factors:
- Increasing incidence of chronic wounds: The global prevalence of chronic wounds is estimated to be around 9%. This number is expected to grow due to the increasing aging population and rising rates of diabetes and obesity.
- Growing demand for advanced wound care products: There is a growing demand for advanced wound care products that can promote healing and reduce the risk of infection. This has led to the development of new technologies and products in the wound biologics market.
- Rising awareness about wound care: There is a growing awareness among people about proper wound care techniques, which is driving the demand for advanced wound care products.
- Technological advancements: The development of new technologies such as tissue engineering, regenerative medicine, and stem cell therapy is helping to drive growth in the wound biologics market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Wound Biologics Market Research Report
By Type
Biological Skin Substitutes, Enzyme Preparation, Growth Factor
By Application
Hospital, Drugstore, Others
By Companies
Avita Medical, ConvaTec, Acelity, Cytori Therapeutic, MacroCure, Nuo Therapeutics, Molyncke Health Care, Osiris Therapeutics, Smith And Nephew, Organogenesis, Avita Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Wound Biologics Market Report Segments:
The global Wound Biologics market is segmented on the basis of:
Types
Biological Skin Substitutes, Enzyme Preparation, Growth Factor
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugstore, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Avita Medical
- ConvaTec
- Acelity
- Cytori Therapeutic
- MacroCure
- Nuo Therapeutics
- Molyncke Health Care
- Osiris Therapeutics
- Smith And Nephew
- Organogenesis
- Avita Medical
Highlights of The Wound Biologics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biological Skin Substitutes
- Enzyme Preparation
- Growth Factor
- By Application:
- Hospital
- Drugstore
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wound Biologics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wound biologics are medications that help heal wounds. They can be used to treat a variety of conditions, including skin wounds, cuts, and burns.
Some of the major companies in the wound biologics market are Avita Medical, ConvaTec, Acelity, Cytori Therapeutic, MacroCure, Nuo Therapeutics, Molyncke Health Care, Osiris Therapeutics, Smith And Nephew, Organogenesis, Avita Medical.
The wound biologics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wound Biologics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wound Biologics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wound Biologics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wound Biologics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wound Biologics Market Size & Forecast, 2020-2028
4.5.1 Wound Biologics Market Size and Y-o-Y Growth
4.5.2 Wound Biologics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biological Skin Substitutes
5.2.2 Enzyme Preparation
5.2.3 Growth Factor
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugstore
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wound Biologics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wound Biologics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biological Skin Substitutes
9.6.2 Enzyme Preparation
9.6.3 Growth Factor
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugstore
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biological Skin Substitutes
10.6.2 Enzyme Preparation
10.6.3 Growth Factor
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugstore
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biological Skin Substitutes
11.6.2 Enzyme Preparation
11.6.3 Growth Factor
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugstore
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biological Skin Substitutes
12.6.2 Enzyme Preparation
12.6.3 Growth Factor
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugstore
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biological Skin Substitutes
13.6.2 Enzyme Preparation
13.6.3 Growth Factor
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugstore
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wound Biologics Market: Competitive Dashboard
14.2 Global Wound Biologics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Avita Medical
14.3.2 ConvaTec
14.3.3 Acelity
14.3.4 Cytori Therapeutic
14.3.5 MacroCure
14.3.6 Nuo Therapeutics
14.3.7 Molyncke Health Care
14.3.8 Osiris Therapeutics
14.3.9 Smith And Nephew
14.3.10 Organogenesis
14.3.11 Avita Medical
